NeuroSense Therapeutics
(NASDAQ:NRSN)
$1.43
0.09[6.72%]
At close: Apr 24
$1.43
0[0.00%]
PreMarket: 8:12AM EDT

NeuroSense Therapeutics Stock (NASDAQ:NRSN), Guidance and Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

No data available to display
Date Announced
▲▼
ticker
▲▼
Company Name
▲▼
Period
▲▼
Period Year
▲▼
Min EPS
▲▼
Max EPS
▲▼
Estimate
▲▼
Min Rev
▲▼
Max Rev
▲▼
Revenue Estimate
▲▼
Get Alert

FAQ

Q

What is the most recent guidance for NeuroSense Therapeutics (NRSN)?

A

There have been no specific sales or earnings guidance reported for NeuroSense Therapeutics in recent months.

Browse guidance and forecast on all stocks.